UROCIT-K Drug Patent Profile
✉ Email this page to a colleague
When do Urocit-k patents expire, and when can generic versions of Urocit-k launch?
Urocit-k is a drug marketed by Mission Pharma and is included in one NDA.
The generic ingredient in UROCIT-K is potassium citrate. There are two hundred and forty drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urocit-k
A generic version of UROCIT-K was approved as potassium citrate by RISING on June 9th, 2006.
Summary for UROCIT-K
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for UROCIT-K |
| What excipients (inactive ingredients) are in UROCIT-K? | UROCIT-K excipients list |
| DailyMed Link: | UROCIT-K at DailyMed |
Recent Clinical Trials for UROCIT-K
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Early Phase 1 |
Pharmacology for UROCIT-K
| Drug Class | Anti-coagulant Calculi Dissolution Agent |
| Mechanism of Action | Acidifying Activity Calcium Chelating Activity |
| Physiological Effect | Decreased Coagulation Factor Activity |
Anatomical Therapeutic Chemical (ATC) Classes for UROCIT-K
US Patents and Regulatory Information for UROCIT-K
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharma | UROCIT-K | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 019071-001 | Aug 30, 1985 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mission Pharma | UROCIT-K | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 019071-002 | Aug 31, 1992 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Mission Pharma | UROCIT-K | potassium citrate | TABLET, EXTENDED RELEASE;ORAL | 019071-003 | Dec 30, 2009 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
